Old Web
English
Sign In
Acemap
>
authorDetail
>
Leonardo Sahelijo
Leonardo Sahelijo
Alexion Pharmaceuticals
Immunology
Pharmacodynamics
Dosing
Adverse effect
Tolerability
3
Papers
29
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
DOSAGE ET ADMINISTRATION D'ANTICORPS ANTI-C5 POUR TRAITEMENT
2017
Eric Bachman
David Mitchell
Leonardo Sahelijo
Show All
Source
Cite
Save
Citations (0)
First in Human Single-Ascending Dose Study: Safety, Biomarker, Pharmacokinetics and Exposure-Response Relationships of ALXN1210, a Humanized Monoclonal Antibody to C5, with Marked Half-Life Extension and Potential for Significantly Longer Dosing Intervals
2015
Blood
Leonardo Sahelijo
Arshad Mujeebuddin
David Mitchell
Richard Larouche
Zhao-Xue Yu
Yuchun Zhang
Rekha Patel
Melissa Lasaro
Keith Bouchard
Bruce Andrien
Yi Wang
Paul P. Tamburini
Susan Macdonald
Douglas L. Sheridan
Paresh Soni
Show All
Source
Cite
Save
Citations (17)
Safety and Pharmacokinetics of the Complement Inhibitor TT30 in a Phase I Trial for Untreated PNH Patients
2015
Blood
Antonio M. Risitano
Michael J. Storek
Leonardo Sahelijo
Mittie K. Doyle
Yang Dai
Ilene C. Weitz
Judith Marsh
Modupe Elebute
Casey O’Connell
Austin G. Kulasekararaj
Giridharan Ramsingh
Serena Marotta
Andrzej Hellmann
Ante S. Lundberg
Show All
Source
Cite
Save
Citations (12)
1